Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:gamma-Glutamylalanine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001447 AN002418 Metabolomics of lung injury after allogeneic hematopoietic cell transplantation - Colon ICMS Intestine Mouse Graft versus host disease University of Kentucky abundance & normalized peak area
ST001453 AN002428 Metabolomics of lung injury after allogeneic hematopoietic cell transplantation - Liver ICMS Liver Human Graft versus host disease University of Kentucky abundance & normalized peak area
ST001470 AN002446 Metabolomics of lung injury after allogeneic hematopoietic cell transplantation - Lung ICMS Mouse Graft versus host disease University of Kentucky abundance & normalized peak area
ST001472 AN002448 Metabolomics of lung injury after allogeneic hematopoietic cell transplantation - Small Intestines ICMS SI Mouse Graft versus host disease University of Kentucky abundance & normalized peak area
ST002245 AN003665 Deciphering the metabolomic differences between two fast-growing cyanobacteria, S.elongatus PCC 11801 and 11802 via metabolite profiling Bacterial cells Synechococcus elongatus Indian Institute of Technology Bombay Area Ratios
ST000450 AN000706 Metabolic features of chronic fatigue syndrome Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome University of California, San Diego Area under curve
ST000617 AN000946 Validation of the application of targeted metabolomic appraoch in the diagnosis of CFS Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome University of California, San Diego Area under curve
ST000903 AN001469 Pharmacometabolomic analysis of rat hippocampus and plasma in response to chronic stress and albiflorin treament Blood Rat Stress Beijing Woner Biotech Co. Ltd Area under curve
ST001143 AN001882 Microbial depletion and ozone exposure - Lung tissue (part I) Lung Mouse Asthma Harvard School of Public Health Area under curve
ST001144 AN001886 Microbial depletion and ozone exposure - serum (part II) Blood Mouse Asthma Harvard School of Public Health Area under curve
ST002708 AN004390 Levels of central carbon metabolites in choroid plexus as part of natural diurnal variation Brain Mouse Circadian Rhythm Disorder Boston Childrens Hospital a.u.
ST001639 AN002681 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health AU
ST001855 AN003006 The metabolomic resetting effect of FG4592 in AKI to CKD transition-day 21 (Part 1) Kidney Mouse Kidney disease Children’s Hospital of Nanjing Medical University AUC
ST001850 AN002997 Unbiased LC-MS-based metabolomics analysis for both whole cell and mitochondria metabolites to gain an insight into the role of Tug1/PGC1 axis on metabolite profiles in podocytes Epithelial cells Mouse University of Texas MD Anderson Cancer Center AUC/ngDNA
ST000508 AN000778 Metabolic Profiling of Date Palm Fruits Plant Date palm Weill Cornell Medicine in Qatar Counts per second
ST000867 AN001396 Metabolic Profiling of Date Palm Fruits (part II) Date palm fruit Date palm Weill Cornell Medicine in Qatar Counts per second
ST001402 AN002344 Ontogeny related changes in the pediatric liver metabolome Liver Human Moffitt Cancer Center estimated abundances
ST001403 AN002345 Ontogeny related changes in the pediatric liver metabolome (part-II) Liver Human Moffitt Cancer Center estimated abundances
ST002155 AN003530 Longitudinal metabolomic stool dynamics in primary C. difficile infections Feces Human Bacterial infection Brigham Women's Hospital intensity
ST001775 AN002882 Plasma metabolomics of diverse mouse strains infected with Plasmodium chabaudi Blood Mouse Malaria Stanford University ion counts
ST001953 AN003178 Identifying metabolite changes in human islets treated with Phospho-BAD mimicry and Inflammatory cytokines Cultured cells Human Diabetes Harvard University Ion signal intensity
ST002829 AN004619 Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study Blood Human COVID-19 National Institutes of Health log transformed data
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001324 AN002202 Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress Pacific Abalone Institute of Oceanology, Chinese Academy of Sciences mV*min
ST001474 AN004409 Metabolomics of lung injury after allogeneic hematopoietic cell transplantation - Spleen ICMS Multiple tissues Mouse Graft versus host disease University of Kentucky natural abundance corrected and dry residue normalized peak area
ST001638 AN002680 Metabolomics analysis of Vehicle (DMSO/PBS; (1:1) v/v) and DRB18 (10 mg/kg) treated A549 xenograft tumors Tumor cells Mouse Cancer Ohio University Normalized abundances
ST001865 AN003024 Systemic metabolite changes due to Hypoxia Blood Mouse Northwestern University Peak
ST001866 AN003027 Systemic metabolite changes due to PHD inhibition Blood Mouse Northwestern University Peak
ST001780 AN002890 Comparative analysis of metabolomic profiles in cerebrospinal fluid before and after endurance exercise Cerebrospinal fluid Human UCSD School of Medicine peak area
ST001789 AN002901 Acute metabolomic changes of plasma in response to endurance exercise Blood Human University of California, San Diego peak area
ST002205 AN003608 Effect of Hira loss in the metabolic landscape of Fh1-deficient cells Cultured cells Mouse Cancer CECAD Research Center, University Hospital Cologne peak area
ST002242 AN003660 Hypoxia promotes osteogenesis via regulating the acetyl-CoA-mediated mito-nuclear communication. Cultured cells Mouse CECAD Research Center peak area
ST002498 AN004654 Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort Blood Human Cancer Weill Cornell Medicine peak area
ST000040 AN000060 Heatshock response of C. elegans using IROA (I) Worms C. elegans University of Florida Peak area
ST000040 AN000061 Heatshock response of C. elegans using IROA (I) Worms C. elegans University of Florida Peak area
ST001157 AN001915 The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) Blood Mouse Johns Hopkins University School of Medicine Peak area
ST001212 AN002045 Fish-oil supplementation in pregnancy, child metabolomics and asthma risk Blood Human Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen Peak area
ST001411 AN002361 Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark Blood Human Obesity University of Michigan Peak area
ST001420 AN002375 Metabolomic analysis of patients with recurrent angina Blood Human Angina University of California, San Diego Peak area
ST002461 AN004016 Untargeted metabolomics of HUVECs subjected to hypoxia-reoxygenation Cultured cells Human Hypoxia Tulane University School of Medicine Peak area
ST002492 AN004081 Composition of raw plant-based food items Plant Plants Northeastern University Peak area
ST002505 AN004126 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China Peak area
ST002909 AN004775 Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis Blood Human Melioidosis University of Washington Peak area
ST002754 AN004468 Metabolomics analysis of maternal obesity model Blood Mouse Fatty liver disease University of Bonn Peak Area
ST002531 AN004165 Cellular consumption/release of polar metabolites by mPDAC cells cultured in different culture media conditions Media Mouse Cancer University of Chicago Peak area (m/z)
ST001302 AN002168 Metabolome Profiling of a Fast-growing Cyanobacterium Synechococcus elongatus PCC 11801 under Diurnal Cycle Bacterial cells Synechococcus Indian Institute of Technology Bombay Peak area ratio
ST000452 AN000708 The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data Blood Mouse University of North Carolina Peak values (scaled)
ST001827 AN002963 The pregnancy metabolome from a multi-ethnic pregnancy cohort Blood Human Icahn School of Medicine at Mount Sinai pmoles/l
ST001759 AN002866 Application of the redox metabolite detection method for mouse liver Liver Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001760 AN002867 Application of the redox metabolite detection method for mouse kidney Kidney Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001761 AN002868 Application of the redox metabolite detection method for mouse biofluids Cerebrospinal fluid Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001762 AN002869 Application of the redox metabolite detection method for mouse kidney (part II) Kidney Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001763 AN002870 Application of the redox metabolite detection method for mouse liver (part II) Liver Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001764 AN002871 Application of the redox metabolite detection method for profiling redox state following pharmacologic perturbation with methotrexate Cultured cells Human Boston Children's Hospital, Harvard Medical School ppm
ST001766 AN002873 Application of the redox metabolite detection method for mammalian tissues (part I) Kidney Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001766 AN002873 Application of the redox metabolite detection method for mammalian tissues (part I) Liver Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001768 AN002875 Application of the redox metabolite detection method for mammalian tissues (part III) Kidney Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001768 AN002875 Application of the redox metabolite detection method for mammalian tissues (part III) Liver Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001769 AN002876 Application of the redox metabolite detection method for profiling redox state following pharmacologic perturbations of redox balance in cells (part I) Cultured cells Human Boston Childrens Hospital ppm
ST001770 AN002877 Application of the redox metabolite detection method for profiling redox state following pharmacologic perturbations of redox balance in cells (part II) Cultured cells Human Boston Children's Hospital, Harvard Medical School ppm
ST001771 AN002878 Application of the redox metabolite detection method for profiling redox state following pharmacologic perturbations of redox balance in cells (part III) Cultured cells Human Boston Children's Hospital, Harvard Medical School ppm
ST001772 AN002879 Optimization of redox metabolite detection in mammalian cells (part II) Cultured cells Human Boston Children's Hospital, Harvard Medical School ppm
ST001773 AN002880 Application of the redox metabolite detection method for mouse biofluids (part II) Blood Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001975 AN003223 Anti-oxidative metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (II) Cerebrospinal fluid Mouse Cancer Boston Children's Hospital, Harvard Medical School ppm
ST001978 AN003226 Anti-oxidation metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (V) Cerebrospinal fluid Human Cancer Boston Children's Hospital, Harvard Medical School ppm
ST001979 AN003228 Anti-oxidation metabolism measurement in mammalian cells and tissues by quantitative LC/MS method (VI) Cerebrospinal fluid Mouse Cancer Boston Children's Hospital, Harvard Medical School ppm
ST001983 AN003234 Metabolomic Fingerprinting of Human High Grade Serous Ovarian Carcinoma Cell Lines Ovarian cancer cells Human Cancer University of Oklahoma Health Sciences Center ratio
ST001835 AN002977 Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes Blood Human Idaho Veterans Research and Education Foundation raw area count
ST000899 AN001462 Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling Blood Human Inflammatory bowel disease Vanderbilt University Medical Center raw area counts
ST001400 AN002340 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria Blood Human Malaria New York University Abu Dhabi raw area counts
ST001516 AN002515 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) Blood Human Malaria New York University Abu Dhabi raw area counts
ST001517 AN002518 Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) Blood Human Malaria New York University Abu Dhabi raw area counts
ST001749 AN002848 REACH Metabolomics Study Blood Human Alzheimers disease University of Wisconsin - Madison Raw area counts
ST002818 AN004586 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002819 AN004590 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002820 AN004594 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST001404 AN002346 Ontogeny related changes in the pediatric liver metabolome (part-III) Liver Human Moffitt Cancer Center Relative Abundance
ST002106 AN003445 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 1) Blood Plasmodium falciparum Malaria Monash University relative intensity
ST002107 AN003447 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) Blood Plasmodium falciparum Malaria Monash University relative intensity
ST002108 AN003448 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) Blood Plasmodium falciparum Malaria Monash University relative intensity
ST002088 AN003406 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health relativeMedian
ST002089 AN003410 Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. Blood Human COPD National Jewish Health relativeMedian
ST002017 AN003287 Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) Blood Human Vanderbilt University Medical Center scaled imputed
ST002018 AN003288 Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) Feces Human Vanderbilt University Medical Center scaled imputed
ST002019 AN003289 TIPs Metabolomics (blood) Blood Human Vanderbilt University Medical Center scaled imputed
ST000930 AN001524 Define alterations in the gut metabolome of mice infected with C. difficile Intestine Mouse North Carolina State University scaled intensity
ST000974 AN001595 GC6-74 matabolomic of TB (Part 1: Plasma) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
ST000975 AN001596 GC6-74 metabolomics of TB vs healthy (Part 2: Serum) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
ST000976 AN001597 GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
ST001753 AN002856 Modifying Chromatography Conditions for Improved Unknown Feature Identification in Untargeted Metabolomics Blood Human University of Michigan Total Intensity Units
ST001119 AN001830 Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability Bacterial cells Mouse Cancer University of Chicago uM
  logo